A Phase Iii Trial-In-Progress Comparing Tislelizumab Plus Chemotherapy With Placebo Plus Chemotherapy As First-Line Therapy In Patients With Locally Advanced Unresectable Or Metastatic Gastric Or Gastroesophageal Junction (G/Gej) Adenocarcinoma.
JOURNAL OF CLINICAL ONCOLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要